WASHINGTON — Eric Lander, President Biden’s nominee to lead the White House’s science policy office, easily weathered a Senate confirmation hearing on Thursday that started with an examination of his past controversies but ended in a more philosophical discussion of the future of American research.
The renowned genetics researcher pledged that if confirmed, he would leverage U.S. science to drive a new wave of disease cures. The Biden administration, he said, would also work to address climate change, increase access to STEM careers for women and people of color, and address an array of other issues ranging from cybersecurity to broadband access.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
About the Author Reprints
